For junior faculty with clinical and/or teaching responsibilities, it's difficult to find enough time to prioritize their own research. On top of time constraints, junior faculty members often have limited experience in the precise art of writing successful federal grant applications and managing large grants. It takes time, training, and funding to accelerate a research career. The KL2 Career Development Program provides these resources to investigators to do just that.
A new study led by University of Kentucky Markey Cancer Center researcher Peter Zhou shows that targeting Twist, a nuclear protein that is an accelerant of the epithelial-mesenchymal transition (EMT) program in human cells, may provide an effective approach for treating triple-negative breast cancer.
Triple-negative breast cancer has an activated EMT program, which is a process that provides cells with the increased plasticity (or flexibility) to adapt to stressed environments during embryonic development, wound healing, tissue fibrosis and metastasis.
The Office of Sponsored Projects Administration has created a new webpage entitled "Investigator's Survival Guide". This new page offers guidance to investigators at on topics ranging form Proposal Submission to Responsible Conduct of Research. To view the page, click here.
NIH Shared Instrumentation Grant Program and Required Information for Letter of Institutional Commitment
The NIH Office of Research Infrastructure Programs (ORIP) supports the Shared Instrumentation Grant program for major research equipment costing between $100,000 and $600,000. ORIP intends to commit approximately $40 million in FY2015 to fund approximately 80 new awards. The NIH deadline is March 21, 2014.
Renowned chemist, novelist and playwright Carl Djerassi, known for his work in organic chemistry and as a father of insect and human birth control, will take part in several events being held Feb. 13-15, at the University of Kentucky.
During his visit to the Bluegrass, Djerassi will participate in three events. He will first serve as the featured speaker at a luncheon for business and academic leaders.
As part of the recent announcment that NIH is operating under a continuing solution, it was announced that the salary cap has been increased by 1%. To read more about the continuing resolution and the salary cap increase, click here.
Sally Rockey, NIH Deputy Director for Extramural Research, released in a recent blog post the FY 2013 information for research applications, funding and awards. To read her blog post, click here.
Dr. Rockey releases a blog post every week with benefical information for every researcher. To sign up for Dr. Rockey's blog, called Rock Talk, click here.
A new lecture series presented by mUsiKcare will highlight wellness and health care benefits of music programs like the 好色先生 piano courses for individuals 50 years of age and older. A transcript of this video can be found here. Video by Jenny Wells/好色先生 Public Relations and Marketing.
Donna Wilcock, assistant professor in the 好色先生 Department of Physiology and the 好色先生 Sanders-Brown Center on Aging, has been invited to join the editorial board of The Journal of Neuroscience in 2014 as an associate editor in the Neurobiology of Disease section.
She was been selected by the senior and reviewing editors of the journal based on her expertise and history of reviews. As an associate editor, Wilcock will provide frequent reviews as well as suggesting appropriate reviewers for manuscripts.
Ana Bastos-Carvalho, a visiting scholar in the Ambati research group in the Department of Ophthalmology and Visual Sciences at the 好色先生, received the Global Ophthalmology Research Award from Bayer HealthCare for her research, "Mechanisms of geographic atrophy expansion in age-related macular degeneration." http://www.bayer-ophthalmology-awards.com/html/b-about-c.html
鈥淲e are studying age-related macular degeneration (AMD), the disease responsible for most cases of legal blindness in the American elderly population鈥, Bastos-Carvalho said.
The University of Kentucky is partnering with KNODE Inc. to promote and connect 好色先生 researchers with colleagues and potential collaborators worldwide.
Through a 好色先生-specific portal (search.knodeinc.com/ukentucky) the KNODE platform helps individual researchers, academic institutions and companies share scientific knowledge, particularly in the biomedical field.
There's a proverb in the business world that says, "If you don鈥檛 know, hire someone who does."
In the world of translational research, the saying might go like something this: "If you don't have the expertise or resources, collaborate with someone who does."
The nature of translational science -- the process of turning a basic science discovery into applications for human patients -- is inherently multidimensional.
A new study led by University of Kentucky researchers suggests that activating the tumor suppressor p53 in normal cells causes them to secrete Par-4, another potent tumor suppressor protein that induces cell death in cancer cells. This finding may help researchers decipher how to inhibit the growth of tumors that have become resistant to other treatments.
Loss of the tumor suppressor p53 often contributes to therapy resistance in tumors.
Dr. Jayakrishna Ambati, professor and vice chair in the Department of Ophthalmology and Visual Sciences and professor in the Department of Physiology at the 好色先生,is one of 11 recipients of the 2014 Harrington Scholar-Innovator Awards given by the Harrington Discovery Institute at University Hospitals (UH) Case Medical Center.
